Gene delivery strategies targeting stable atheromatous plaque.
Conventional therapeutic options to treat chronic angina pectoris are pharmacological interventions, coronary bypass surgery (CABG) and percutaneous coronary intervention (PCI). In animal models, it was shown that gene delivery strategies harbour an exciting potential to support and maybe even repla...
Auteurs principaux: | Van-Assche, T, Huygelen, V, Crabtree, M, Antoniades, C |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2013
|
Documents similaires
-
Gene therapy targeting inflammation in atherosclerosis.
par: Van-Assche, T, et autres
Publié: (2011) -
Targeting vascular redox biology through antioxidant gene delivery: a historical view and current perspectives.
par: Van Assche, T, et autres
Publié: (2011) -
Periodontal pathogens in atheromatous plaque
par: Saroj K. Rath, et autres
Publié: (2014-01-01) -
Macrophages in Atheromatous Plaque Developmental Stages
par: Alexander von Ehr, et autres
Publié: (2022-04-01) -
Letter to the Editor. Atheromatous Plaque Vulnerability — the Neglected Vulnerable Carotid Plaques
par: Péter Levente
Publié: (2017-09-01)